| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000505041 |
| P356 | DOI | 10.1038/SJ.GT.3300733 |
| P698 | PubMed publication ID | 9930315 |
| P5875 | ResearchGate publication ID | 13359556 |
| P2093 | author name string | Y Li | |
| A M Maguire | |||
| J Bennett | |||
| Y Zeng | |||
| R Bajwa | |||
| L Klatt | |||
| P433 | issue | 9 | |
| P921 | main subject | Adenoviridae | Q193447 |
| cell death | Q2383867 | ||
| photoreceptor protein | Q7187894 | ||
| P304 | page(s) | 1156-1164 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse | |
| P478 | volume | 5 |
| Q42102379 | A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors |
| Q35961539 | A short N-terminal domain of HDAC4 preserves photoreceptors and restores visual function in retinitis pigmentosa |
| Q40592978 | Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina. |
| Q35566831 | Adeno-associated viral vectors for retinal gene transfer. |
| Q28353985 | An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse |
| Q43823388 | Bcl-2 expression during the development and degeneration of RCS rat retinae |
| Q45864521 | Characterization of adenovirus p21 gene transfer, biodistribution, and immune response after local ocular delivery in New Zealand white rabbits |
| Q45742602 | Cross-species comparison of in vivo reporter gene expression after recombinant adeno-associated virus-mediated retinal transduction |
| Q30830231 | Early postnatal Müller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic mice |
| Q34404709 | Expectations in the treatment of retinal diseases: neuroprotection |
| Q33884609 | Expression characteristics of dual-promoter lentiviral vectors targeting retinal photoreceptors and Müller cells. |
| Q43681104 | Expression of Bcl-2 during the development of rabbit retina |
| Q37950225 | Gene supplementation therapy for recessive forms of inherited retinal dystrophies. |
| Q34084443 | Gene therapy and retinitis pigmentosa: advances and future challenges |
| Q44752242 | Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus |
| Q34996908 | Gene therapy for genetic and acquired retinal diseases |
| Q35160142 | Gene therapy for ocular diseases |
| Q34701404 | Gene therapy for retinal and choroidal diseases |
| Q33837123 | Gene therapy in the CNS. |
| Q36147481 | Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients |
| Q28365551 | Gene transfer mediated by recombinant baculovirus into mouse eye |
| Q44420163 | HSV-1 VP22 augments adenoviral gene transfer to CNS neurons in the retina and striatum in vivo |
| Q27307727 | Lentiviral expression of retinal guanylate cyclase-1 (RetGC1) restores vision in an avian model of childhood blindness |
| Q43564494 | Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier |
| Q44050073 | Morphological and functional abnormalities in the inner retina of the rd/rd mouse. |
| Q41987307 | Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model |
| Q44607823 | Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis. |
| Q24536217 | On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention |
| Q40792353 | Ophthalmology in the post-genomic era |
| Q34120951 | P2Y2Receptor Agonist INS37217 Enhances Functional Recovery after Detachment Caused by Subretinal Injection in Normal andrdsMice |
| Q48169737 | Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. |
| Q30977623 | Pharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes |
| Q33942183 | Recent advances in the molecular basis of inherited photoreceptor degeneration |
| Q35125708 | Recent developments in ocular gene therapy |
| Q35210756 | Republished review: Gene therapy for ocular diseases |
| Q28552843 | Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist |
| Q36616998 | Retinal degeneration depends on Bmi1 function and reactivation of cell cycle proteins |
| Q21203028 | Retinitis pigmentosa |
| Q29616538 | Retinitis pigmentosa |
| Q35306158 | Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. |
| Q44495826 | Simian immunodeficiency virus-based lentivirus vector for retinal gene transfer: a preclinical safety study in adult rats |
| Q36439639 | Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina |
| Q46471965 | Stem cell-based therapies for retinal disorders |
| Q43661756 | Strain-dependent anterior segment neovascularization following intravitreal gene transfer of basic fibroblast growth factor (bFGF). |
| Q34735778 | Suppression of laser-induced choroidal neovascularization by intravitreal injection of tristetraprolin. |
| Q34561531 | Vector platforms for gene therapy of inherited retinopathies. |
| Q40648820 | Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers |
| Q33279531 | XIAP protection of photoreceptors in animal models of retinitis pigmentosa |
Search more.